• Free Trial
  • Audio & Video Podcasts
  • Trade Policy
  • Press Releases
  • Events
  • Contact Us
  • WisPolitics
Search
Friday, November 20, 2026
  • Home
WisBusiness.com WisBusiness
WisBusiness.com WisBusiness.com
  • Free Trial
  • Audio & Video Podcasts
  • Trade Policy
  • Press Releases
  • Events
  • Contact Us
  • WisPolitics
Home PRESS RELEASES Canopus BioPharma Strengthens Its CB1400 Platform Technology for Mucositis and Oncology Treatments...

Canopus BioPharma Strengthens Its CB1400 Platform Technology for Mucositis and Oncology Treatments Through License Agreement with Wisconsin Alumni Research Foundation

June 18, 2008
http://www.businesswire.com/news/home/20080618005636/en
Facebook
Twitter
Google+
Pinterest
WhatsApp

    RELATED ARTICLESMORE FROM AUTHOR

    Michael Fields Agricultural Institute and Wisconsin Organics: Awarded $97,429 to strengthen markets for Wisconsin certified organic products

    Sheboygan County Economic Development Corporation: New East Wind Dojo to open in Sheboygan, bringing martial arts and self defense training to the community

    UW-Platteville: Chancellor names Attenborough as interim provost

    - Advertisement -

    For questions or assistance, please contact: Colin Schmies at schmies@wispolitics.com or 608-206-0476

    WisBusiness.com
    • Subscribe
    • Advertise
    • Press Releases
    • Audio & Video Podcasts
    • RSS
    ©2026 WisBusiness.com All rights reserved.
    Edit with Live CSS
    Save
    Write CSS OR LESS and hit save. CTRL + SPACE for auto-complete.